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Activity Testing of Alveolar Macrophages
and Changes in Surfactant Phospholipids
after Irradiation in Bronchoalveolar
Lavage: Experimental and Clinical Data
by F. Steinberg,' B. Rehn,2 R. Kraus,2 K. Quabeck,3 J.
Bruch,2 D. W. Beelen,3 U. W. Schaefer,3 and
C. Strefferl
Thisstudypresentsresultsofbronchoalvolarlavage(BAL)afterirradiationtothelungs inmiceaswell asclinicaldata.
ThenumberofBALcells,mainiymacrophages,lymphocytes, andgranulocytes, changed inatime-dependent manner.
Thephagocytic activity ofthemacrophagesmeasured asthephagocytosisofmicrobeads andmeasuredastheesterase
activityalsoshowedastrongtime-dependent increaseduringtheacutephaeupto21daysafterirradiation. Thecontents
ofsurfactantphospholipids(SF)andsphingomyelin (SPH;asaparameterforceil death)werequantifiedbyHPLC. Both
weresignificantly changed between day 2and21 after irradiation. ThreeBALsofa patientwith idiopathic interstitial
pneumonitis, whohadreceived anallogenic bonemarrowgraftaftertotalbodyirradiationwith 10Gy,showed similar
effectsinthecellularandsrfactantparametes Thesedataindicatethattherearepsitiveinteractionsbetweenthenumber
ofdifferent BALcells, macrophageactivity, andSFand SPHcontent inthepreclinical modelofthe mouse aswell asin
theclinical situation afterlungirradiation.
Introduction
In thoracic and total body irradiation (TBI), the lung re-
presents a dose-limiting organ. In the setting ofbone marrow
transplantation, TBIprovides ahigh immunosupressiveand an-
titumor effect. However, a number of patients may develop
idiopathic interstitial pneumonitis (IIP), which maypartiallybe
inducedby radiation injury. Theclinical courseofIIPisidentical
totheadultrespiratory distress syndrome(ARDS) inpolytrauma
patients, which candevelopdramatically andattain a stagethat
can no longer be controlled by therapy. The underlying patho-
genic mechanism is still unknown.
Theepithelial lining fluid (ELF) ofthe respiratory tract may
serve as an indicator ofpulmonary injury ordisease. ELF can-
notbeobtained aseasily asblood orurine, butbronchoalveolar
lavage (BAL) with physiological saline can be used to sample
ELF inanimalexperimentsandinclinical situations. Recently,
the analysis of BAL has proved useful for detecting an in-
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flammatory response in the lungs ofanimals exposed in tox-
icology studies, and there is optimism about the use of BAL
analysis as an early predictor of late-occurring pulmonary
disease(I). BALcanbeusedasanaidinstudyingthepathogenic
mechanism ofdiseases such as ARDS or IIP. However, these
techniqueshavenotgenerally beenusedinassociation withTBI.
Up to now, only few largely experimental animal data are




phages, andlymphocytes), assaysofmacrophage esteraseactivi-




ofmorbidity and mortality in patients (2-4) undergoing bone
marrowtransplantation with apreconditioning wholebody ir-




Radiation. Asingledoseof10Gy (1 Gy/min) wasapplied to
thethoraxofHeiligenbergermice(male, weight28-35g)usingSTEINBERGETAL.
an X-ray machine (Stabilipan, Siemens, Erlangen, FRG) op-
erating at 240 kV and 15 mA with a copper filter of0.5 mm
thickness. The field size was 18 x 16 cm and the focus skin
distance was47cm. Theanimalsweregiven5 tg/gbodyweight
penobarbital intraperitoneally foranesthesia.
Cell Differentiation. We sacrificed the animals by intra-
peritoneal injectionofbarbiturate2, 7, 14, and21 daysafterir-
radiation. Thelungwasdissectedfreeandthetracheacannulated
withasyringeneedle. Bymeansofasyringe,thelungwaswashed
with sterile, ice-coldphysiological saline (10timeswithaliquots
of0.8 mL). TheBAL fluid was centrifuged at 180g for 10 min.
We washed the cells with phosphate-buffered saline (PBS
DulbeccowithoutCa2e andMg2+, pH7.4; Seromed, FRG) and
resuspended in incubation medium and counted in a Coulter
counter (CoulterElectronics, Harpenden, UK). Macrophages,
lymphocytes, andgranulocytes werecounted. Cellviability after
washingwasgreaterthan95% asdeterminedbytrypanbluedye
exclusion.
MacrophageActivity. Atotalof0.5-1 x 106alveolarmacro-
phages (2-mL cell suspension) waspreincubated inamoistat-
mosphere containing 5% CO2 (plastic petri dishes, 35 mm in
diameter). Fluorescent and carboxylated latex beads (2itm in
diameter) were added 1 hr later. Theparticle to cell ratio was








ing System Quantimet 970 (Cambridge, UK) (9), the optical
densityofeachindividualcellwasmeasuredusingabrightlight
microscope. With the help of grey value calibration in the
measuring system, 64 different channels could bedetected. A
distributionhistogramwaspreparedfromthemeanvaluesofall
cells using the SAS software (SAS Institute Inc., Cary, NC).
QuantificationofSphingomyelin. Phospholipids weremeas-
ured after separation by high pressure liquid chromatography
(HPLC) (Kronton, Munich, FRG) ataconstanttemperatureof
30°Candflowrateof1 mL/minusingaBiosilHP1O, 10umcol-
umn (250 x 4mmi.d.)andaprecolumnofBio-SilHP-10, 40 x
4.6mm(BioRad, Munich, FRG)at202-210nmwithanUvikon
detector(Kontron, Munich, FRG) (10). Thetotalphospholipid
contentandsphingomyelin (SPH) wereextractedbythemethod
of Folch et al. (11) and pooled for each group. For reference
studiesandcalibration, thephospholipidswerepurchasedfrom
Sigma (Munich, FRG).
CaseReport. A43-year-old malewith chronicmyeloid leu-
kemia received an allogenic marrow graft from his HLA-
identicalbrotherafterreceiving fractionatedwholebodyirradia-
tionof4 x 2.5Gy(lungdose: 4 x 2.0Gy)and 120mg/kgbody
weightcyclophosphamide forconditioning. Onehundredseven
daysaftertransplantationhedevelopedan IIPwithadistinctcen-
tral cyanosis (Po2 54 mmHg, Pco2 32.5 mm Hg, pH7.44). To
obtainadiagnosisoftheunderlyinglungdisease, BALwasper-
formedunderlocalanesthesiawithafibreopticbronchoscopein










was significantly lower than in control group (Fig. 1). It is of
special interest that the first value (2 days after radiation) was






both cases, the day 21 value shows a maximum, significantly
highervaluethanthecontrols.
Macrophage Activity. The phagocytic activity of the BAL
macrophages, measured as the number of cells with phago-
cytizedbead.s, showedasignificantdecreaseinthepercentageof
cells onday21 afterirradiation (Fig 5). Similarly, the esterase
activity inthe64measured channelsofoptical density showed
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FiGURE 1. Totalcell countinbronchoalveolarlavageofirradiatedlung(10Gy)
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FIGURE 2. Numberofmacrophages in bronchoalveolar lavage ofirradiated
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FIGURE 3. Number ofgranulocytes in bronchoalveolar lavage ofirradiated









FIGURE 4. Number oflymphocytes in bronchoalveolar lavage ofirradiated

















Measured by Optical Transmission
FIGuRE 6. Shiftindistributionofmacrophagesclassifiedbytheiresteraseac-














FIGURE 5. Percentage of phagocytizing macrophages in bronchoalveolar
lavageofirradiated lung (10Gy) andcontrol mice. Values show means and
SE (n = 8); significance atp < 0.05.
Phospholipid Surfactant and Sphingomyelin. An initial
depression inthetotalphospholipid contents seen onday7, after
which the values rose again significantly above control levels




UP, twoconsecutive BALs werecarried out onday 107and 109
aftertransplantation. There were nosignsofbacterial, viral, or
fungalinfections,butasignificantriseoflymphocytesandgranu-
locytes indifferential cytology. Onthebasisofthesefindings, no




FiGuRE 7. (A) Ibtal sur&ctantphospholipid content and (B) sphingomyelin in
bronchoalveolar supernatant ofirradiated lung (10Gy) and control mice.
Values show means an SE(n = 8).
Instead, prednisone wasadministeredIV at adoseof75 mg/kg
bodyweightdaily andfromday4onwardgivenper os at adose
of40mg/kgdaily, whichafter3daysled to aPo2of67 mmHg
andafter 15days to aPo2of80 mm Hg. Theradiological signs
ofinterstitial pneumonitis cleared completely after 4 weeks of
prednisone therapy. Acontrol BAL wascarried out onday 145
aftertransplantation(= 35daysafterstartofthetherapy). Table
1 showsthatthetotalcellcount onday 107aftertransplantation
wasrelativelylow. Inparticular, thelownumberofmacrophages
as well as the numerous lymphocytes and granulocytes are in-
dicativeofanacuteprocesswithensuingimmunodepression. On









Onday 145 aftertransplantation, thedecreaseintotalcell count
and thereduced numberofgranulocyteswith aconcomitant in-
crease inmacrophages indicatethattheacutephaseisbeginning
todecline. Thehigh levelsofSPH(Table2) onday 109pointto
a massive destruction ofcells. On day 145, the percentage of
macrophagesclearly rose, whilethatoftheSPH wasapparently
lowered; thehealing phase had not set in, as made evident by
these parameters. Table 3 shows the activity of the macro-
phages. Here, incontrast, nosignificantchangesinthe macro-
phage activity can be seen. The BALphospholipid content in-
creases more than 11-fold up to day 145 after transplantation.
The amountofSPH, which was stillbelowthelevelofdetection
on the first day ofBAL, reached a maximum in parallel to the
highest numberofmacrophages (Table2) and total cell counts
(Table 1).
Discussion
Thelung hasbeenshown tobe adose-limiting organbothfor
TBI in bone marrow transplantation and after partial-body ir-
radiationofthethorax (13-16). AreviewbyHamilton etal. (17)
of clinical reports on damage to the lung after bone marrow
transplantation lists anumberofdifferent symptoms both forthe
acute phase (up to 100 days after radiation) as well as the late
phase. The radiation effect on the lung has been investigated
earlier in experimental animals (18-20).
BAL, in particular the measurement ofphospholipids, has
beenwidely used ininvestigatingseptic orpolytraumatic shock-
induced ARDS (21) and severeinfantrespiratorydistress syn-
drome (IRDS) (22), as well as in determining effects oftoxic
drugs and dust to the lung (23-25). The importance ofsurfac-
tant phospholipids has been reported (26-28). There are a
Table 1. Totalcellcounts, macrophages, granulocytes, andlymphocytes in
thebronchoalveolar lavageofa43-year-old patient withidiopathic
interstitial pneumonitis after bone marrow transplantation.
Days after Total cell count, Macrophages, Lymphocytes, Granulocytes,
transplant cells/mL BAL % % %
107 820,000 14 43 43
109 4,070,000 17 48 35
145 800,000 48 27 25
BAL, bronchoalveolar lavage.
Table 2. Surfactant and sphingomyelin content in the bronchoalveolar
lavage ofa43-year-old patientwith idiopathicinterstitial pneumonitis after
bone marrow transplantation.














numberofimportant indications that, in terms oftheunderly-
ing pathogenic mechanisms, ARDS and IIP are somewhat
similar to radiation-induced dysfunction (29). BAL gives in-
sights intotheregulatoryandfunctional processes inthelungs
beforelargermorphologicalchanges occur. Changesinthe sur-
factant phospholipid content are controlled by the P II cells,
which can secreteregulatorymediatorsubstances. Asdescrib-
ed (unpublished observations), significant short-term effects
after irradiation (2hr) are seen in thecellularandbiochemical
alveolarmicroenvironment. Thesefindingscouldalsobe seen
aftertotalbody irradiationofbeagles(4.2 Gy6Co) (Quabeck
and Rehn, personal communication). The cellular potency
(phagocyticactivity) isalteredby irradiation in atime-depen-
dent manner even after 10 Gy thoracic irradiation.
A rapid response ofthe surfactant phospholipid system has
beendescribedwithsignificantchangesinfractionsofindividual
phospholipids, which shows extremely species-specific values
forthe mouseorrat(30). Italsobecameclearthatthesefractions
showeddifferenttemporal responses. Thesedata maypossibly
extendprevious measurements ofsurfactantphospholipid con-
tent. Thus, Rubin et al. (20) found no changes in single ir-
radiated mouse lungs up to 13 Gy. A further subdivision may
perhapshaveshownsuchchanges even atlowdoses. Itmustbe
pointed outherethatthebiological functionsofindividual com-
ponents areonly poorly understood (26-28). However, other
areasofmedicinehaveincreasingly recognizedtheclinical im-
portanceofsurfactantphospholipids. Thesubstitutionofsurfac-





mological complications of30-60% inpatientsconditionedwith
highdoseradio-andchemotherapy forbone marrowtransplants
(2,6) showsthat aclarificationofthesepathogenicmechanisms
achievesparticularly urgentclinicalsignificance. Inthis respect
suchBALstudies arealreadybeingcarriedoutinEsseninbone
marrow transplant and shock-lung patients.
The aim ofthe present investigations was to clarify mecha-
nisms. Itcould be shownthatthere was an increase in the sur-
factantphospholipidcontentandinthenumberofgranulocytes
and lymphocytes before acute inflammation. The alveolar
system responds with amarkedreduction inthetotalsurfactant
phospholipid content and number of macrophages. The
macrophages ofthepatienthaveapparently notbeendamaged
intermsofviabilityandfunction; thiscouldbedefinitelyshown
by the means ofviable staining and functional testing oftheir
phagocytic activity. The decrease in the total cell count is
possibly aresultofthedecreasedsupplyfromthebone marrow,
whichhasbeendamaged. Thesefactorstogetherthenlead to a
collapseoftheentiresurfactant-P IIcells-alveolarmacrophage
system. Previous studieshave shownthat achronic, irreversi-
ble process of fibrosis then occurs in this interaction of the
alteredalveolarmicroenvironment andtheinterstitium. Based
onthis case report, itcouldbeshownthattheprednisone treat-
ment a) stimulated the production ofsurfactant phospholipid
tremendouslyandb)bysuppressing aprobablepulmonarygraft
vesushost responseallowed sufficientmacrophages to comein.
As a result, the escalation ofthe acute inflammatory response
was able to be cut offinthe alveolarmicroenvironment.
107 500,000 82 17
109 500,000 79 21
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